The Rising Contagious Disease Is Fueling The Market Growth Due To The Increasing Need For Rapid Diagnosis And Containment: A Significant Driver Propelling The Point Of Care Infectious Disease Testing Market In 2025

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Point Of Care Infectious Disease Testing Market Size and Projected Growth Rate?
The point of care infectious disease testing market has seen a dramatic increase in size lately. It is projected to increase from $4.21 billion in 2024 to $4.79 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 14.0%. Factors like the demand for prompt diagnostic services, elevating occurrence of infectious illnesses, increased awareness about TH*Care, rising TH*Care spending, and the growing acceptance of home care and self-testing solutions have led to this steady growth during the historic period.

There is an anticipated quick expansion in the market size of point of care infectious disease testing in the upcoming few years. Proliferation to $8.02 billion has been forecasted by 2029, with a compound annual growth rate (CAGR) of 13.7%. Factors contributing to this growth within the forecast period include an amplified requirement for rapid diagnostic procedures, escalating incidence of infectious diseases, escalating utilization in remote areas and settings with limited resources, a shift towards decentralized TH*Care systems, governmental initiatives and funding support. Major TH*Coming trends within this period involve the progression in molecular diagnostics, improvements in point of care testing devices, breakthroughs in biosensors and detection technologies, progression in mobile health applications, and innovative collaborations between TH*Care service providers and technology firms.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp

What Are the Major Segments in the Point Of Care Infectious Disease Testing Market?
The point of care infectious disease testing market covered in this report is segmented -

1) By Product: Kits And Reagents, Instruments
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases
4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users

Subsegments:
1) By Kits And Reagents: Test Kits, Reagents
2) By Instruments: Portable Devices, Automated Analyzers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp

What Are The Driving Point Of Care Infectious Disease Testing Market Evolution?
The escalating prevalence of contagious illnesses is projected to stimulate the expansion of the point of care infectious disease testing market. As infectious diseases can be spread from person to person through direct exposure, airborne particles, or other transmission methods, the uptick in these diseases can be chiefly attributed to increased human mobility. With people moving more freely across regions and countries, infectious agents can be spread more quickly and broadly. The speed and accuracy of the point of care infectious disease testing significantly aid the detection and diagnosis of such diseases, enabling prompt treatment and curbing community spread. For instance, the UK Health Security Agency reported in June 2024 that from the 40th week of 2022 to the 15th week of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. This is in stark contrast to the previous flu season, which saw just 182 admissions across 114 trusts, climbing to 316 by the 39th week of 2022. Consequently, the surge in contagious illnesses is fueling the growth of the point of care infectious disease testing market.

Which Firms Dominate The Point Of Care Infectious Disease Testing Market Segments?
Major companies operating in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron TH*Care Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc.

What Are the Major Trends Shaping the Point Of Care Infectious Disease Testing Market?
Large corporations active in the infectious disease testing market at point-of-care are prioritizing incorporation of cutting-edge technologies, like exclusive microfluidic technology, to augment test precision, decrease time-to-results and optimize patient outcomes. The term proprietary microfluidic technology pertains to specific systems used to manipulate minimal fluid volumes at a micro level, enabling swift, exact and cost-effective analyses. This aids the point of care (POC) infectious disease testing by facilitating quick on-site detection of pathogens, combining sample collection, analysis, and result generation, hence propelling diagnostic speed and accessibility without the requirement of centralized laboratory testing. For example, in June 2023, the diagnostics company Sysmex Corporation from Japan introduced the PA-100 AST System to Europe, presenting the world's first point-of-care solution for direct detection of antimicrobial susceptibility. Applying sophisticated microfluidic technology, the system allows swift detection of bacterial infections and assessment of antimicrobial efficacy, considerably reducing the processing time compared to traditional methods. It includes a compact, desktop-based analyzer and single-use sample cartridges, making it suitable for near-patient environments such as primary care clinics. Thoughtfully designed to expedite more precise antimicrobial therapy decisions, the system augments the global fight against antimicrobial resistance by enhancing diagnostic efficiency.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/point-of-care-infectious-disease-testing-global-market-report

Which Is The Largest Region In The Point Of Care Infectious Disease Testing Market?
North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Point Of Care Infectious Disease Testing Market?
2. What is the CAGR expected in the Point Of Care Infectious Disease Testing Market?
3. What Are the Key Innovations Transforming the Point Of Care Infectious Disease Testing Industry?
4. Which Region Is Leading the Point Of Care Infectious Disease Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.